Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome
Hassan, A., Elhakim, I., Elshenawy, M. (2019). Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome. EKB Journal Management System, 14(2), 20-24. doi: 10.21608/geget.2019.67035
Ahmed Hassan; Ihab Elhakim; Mohammed Elshenawy. "Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome". EKB Journal Management System, 14, 2, 2019, 20-24. doi: 10.21608/geget.2019.67035
Hassan, A., Elhakim, I., Elshenawy, M. (2019). 'Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome', EKB Journal Management System, 14(2), pp. 20-24. doi: 10.21608/geget.2019.67035
Hassan, A., Elhakim, I., Elshenawy, M. Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome. EKB Journal Management System, 2019; 14(2): 20-24. doi: 10.21608/geget.2019.67035

Effect of galactose on proteinuria in pediatric steroid resistant nephrotic syndrome

GEGET
Article 4, Volume 14, Issue 2, December 2019, Page 20-24  XML PDF (427.37 K)
Document Type: Original Article
DOI: 10.21608/geget.2019.67035
View on SCiNiTO View on SCiNiTO
Authors
Ahmed Hassan email orcid 1; Ihab Elhakimorcid 2; Mohammed Elshenawy1
1Pediatrics department, Children Hospital, Ain Shams University, Cairo, Egypt.
2Pediatrics department, Children Hospital, Head of Pediatric Nephrology Unit, Ain Shams University, Cairo, Egypt.
Abstract
Introduction
Proteinuria in steroid resistant nephrotic syndrome (SRNS) is associated with permeability factor (PF). Galactose has been shown to bind with PF, preventing its interaction with podocyte glycocalyx, and oral administration of galactose may lead to reduction of proteinuria.
 
Aim of the study
To study the effect of galactose on proteinuria in pediatric patients with steroid-resistant 
nephrotic syndrome.
 
Patients and methods
A prospective pilot clinical trial was conducted to investigate the effect of oral galactose on 
proteinuria in children with SRNS. Seven pediatric subjects with idiopathic SRNS were treated with 
oral galactose (0.2 g/Kg/dose twice daily) for 16 weeks. Monitoring parameters of improvement include clinical; vital signs, weight, absence of edema, frequency of albumin infusion, number of relapse, hospital admission and laboratory; 24 hour urine protein, serum albumin and serum creatinine. 
 
 Results
Study included seven patients, three of them showed clinical and laboratory improvement from the start till the end of therapy. One patient showed only clinical improvement from the start till the end of the therapy. Another patient improved clinically only after 8 weeks and then improved clinically and laboratory after 16 weeks. One patient was late responder (improved clinically and laboratory after 16 weeks) and one did not improve both clinically and laboratory all through the study.
 
 Conclusion
The addition of galactose to conventional therapy in idiopathic SRNS is associated with clinical &/or laboratory improvement in most cases. Galactose intake may decrease the need of albumin infusion in resistant cases and hence, need for hospital admission.
 
Keywords
Steroid resistant nephrotic syndrome; Proteinuria; galactose
Statistics
Article View: 219
PDF Download: 384